Human Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) ELISA Kit

A quantitative immunoassay kit from Assay Genie, this LRG1 ELISA reagent targets human Leucine Rich Alpha-2-Glycoprotein 1, a leucine-rich repeat protein implicated in TGF-β signaling, angiogenesis, and inflammatory response pathways. LRG1 levels have been investigated in colorectal and ovarian cancer studies, rheumatoid arthritis research, sepsis biomarker discovery, and diabetic kidney disease models, where it serves as an indicator of disease activity and therapeutic response.

Accepting samples such as serum specimens, plasma specimens, tissue homogenates, cell lysates, and cell culture supernatant fractions, the kit supports both clinical sample analysis and translational cell biology workflows. Reagents arrive as a complete kit with the microplate, capture antibodies, detection antibodies, recombinant standards, and buffer solutions required for running determinations on a standard plate reader. Refrigerated storage preserves antibody activity through the kit's stated shelf life.

Researchers can integrate this LRG1 assay into biomarker discovery programs alongside western blot, immunohistochemistry, flow cytometry, and PCR expression profiling. Downstream investigations often include wound healing assays, vascular pathology studies, and cancer cell line characterization, where LRG1 quantification complements transcriptomic and proteomic readouts. Supplied by Assay Genie for research use only, the kit serves laboratories investigating inflammation, oncology, and vascular biology.